Opthea Ltd (CKDXF) stock
CKDXFOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as CYVNY
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Jun 30, 2025Last filing: 20-F on Sep 15, 2025Score 0/30
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Opthea cash
Cash and short-term investments held at the end of each period.
Opthea's cash was $48.44M at Jun 30, 2025. For fiscal 2025 it was $48.44M, down 71.9% from the year before. The highest annual figure on record is $172.47M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $48.44M | -71.9% |
| FY2024 | Jun 30, 2024 | $172.47M | +93.4% |
| FY2023 | Jun 30, 2023 | $89.19M | +99.8% |
| FY2022 | Jun 30, 2022 | $44.63M | -62.2% |
| FY2021 | Jun 30, 2021 | $118.19M | +177.1% |
| FY2020 | Jun 30, 2020 | $42.65M | +182.0% |
| FY2019 | Jun 30, 2019 | $15.12M | -37.2% |
| FY2018 | Jun 30, 2018 | $24.08M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $48.44M | -45.1% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $172.47M | +45.9% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $89.19M | -42.9% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $44.63M | +4.6% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $88.27M | +483.8% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $118.19M | +390.8% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $156.13M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $42.65M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $15.12M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $24.08M | – |
See a number that looks wrong?